title: Anesthesia-Related Carbon Monoxide Exposure: Toxicity and Potential Therapy.
abstract: Exposure to carbon monoxide (CO) during general anesthesia can result from volatile anesthetic degradation by carbon dioxide absorbents and rebreathing of endogenously produced CO. Although adherence to the Anesthesia Patient Safety Foundation guidelines reduces the risk of CO poisoning, patients may still experience subtoxic CO exposure during low-flow anesthesia. The consequences of such exposures are relatively unknown. In contrast to the widely recognized toxicity of high CO concentrations, the biologic activity of low concentration CO has recently been shown to be cytoprotective. As such, low-dose CO is being explored as a novel treatment for a variety of different diseases. Here, we review the concept of anesthesia-related CO exposure, identify the sources of production, detail the mechanisms of overt CO toxicity, highlight the cellular effects of low-dose CO, and discuss the potential therapeutic role for CO as part of routine anesthetic management.
authors.affiliation: From the Department of Anesthesiology, Columbia University Medical Center, New York, New York.
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Levy
mesh_terms: D000769:Anesthesia, Inhalation / Q000009:adverse effects* / Q000639:trends; D018685:Anesthetics, Inhalation / Q000008:administration & dosage* / Q000633:toxicity*; D002248:Carbon Monoxide / Q000008:administration & dosage* / Q000633:toxicity*; D002249:Carbon Monoxide Poisoning / Q000517:prevention & control; D019610:Cytoprotection / Q000187:drug effects / Q000502:physiology; D006801:Humans
chemical_list: D018685:Anesthetics, Inhalation; D002248:Carbon Monoxide